They know it will cost consumers $40 million. But the BBJ reports regulators are effectively letting the proposed MGB-CVS partnership proceed under the assumption it will somehow help relieve the primary-care physician shortage in Massachusetts. … And I have a bridge to sell you in Boston. … The Globe reports David Joyner, chief executive of the $400-billion publicly traded CVS, says it’s all about addressing the primary care crisis in the state. … And I have two bridges to sell you in Boston. … Before the Health Policy Commission’s non-action action, Paul Hattis and John McDonough were giving cautious support to the planned MGB-CVS deal. … But not me. See prior rants here and here.